Dimensional Fund Advisors LP Rapt Therapeutics, Inc. Transaction History

Dimensional Fund Advisors LP

$403 Billion
Q3 2024

A detailed history of Dimensional Fund Advisors LP transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 254,054 shares of RAPT stock, worth $223,567. This represents 0.0% of its overall portfolio holdings.

Number of Shares

254,054

Previous 331,876 23.45%

Holding current value

$223,567

Previous $1.01 Million 49.6%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$1.76 - $3.75 $136,966 - $291,832	-77,822 Reduced 23.45%	254,054 $510,000
Q2 2024 Aug 09, 2024	SELL	$2.89 - $9.38 $650,041 - $2.11 Million	-224,928 Reduced 40.4%	331,876 $1.01 Million
Q1 2024 May 10, 2024	BUY	$6.87 - $26.45 $470,718 - $1.81 Million	68,518 Added 14.03%	556,804 $5 Million
Q4 2023 Feb 07, 2024	SELL	$11.28 - $25.46 $1.12 Million - $2.53 Million	-99,249 Reduced 16.89%	488,286 $12.1 Million
Q3 2023 Nov 09, 2023	BUY	$16.34 - $24.66 $763,878 - $1.15 Million	46,749 Added 8.64%	587,535 $9.76 Million
Q2 2023 Aug 09, 2023	BUY	$16.06 - $21.61 $1.34 Million - $1.8 Million	83,162 Added 18.17%	540,786 $10.1 Million
Q1 2023 May 12, 2023	BUY	$17.19 - $30.8 $535,365 - $959,235	31,144 Added 7.3%	457,624 $8.4 Million
Q4 2022 Feb 09, 2023	BUY	$16.28 - $24.6 $2.08 Million - $3.14 Million	127,505 Added 42.65%	426,480 $8.44 Million
Q3 2022 Nov 10, 2022	BUY	$17.96 - $30.46 $263,598 - $447,061	14,677 Added 5.16%	298,975 $7.19 Million
Q2 2022 Aug 12, 2022	SELL	$10.26 - $23.59 $10,537 - $24,226	-1,027 Reduced 0.36%	284,298 $5.19 Million
Q1 2022 May 13, 2022	BUY	$17.02 - $40.22 $1.18 Million - $2.78 Million	69,238 Added 32.04%	285,325 $6.27 Million
Q4 2021 Feb 09, 2022	BUY	$29.5 - $39.5 $3.08 Million - $4.13 Million	104,551 Added 93.74%	216,087 $7.94 Million
Q3 2021 Nov 12, 2021	BUY	$29.86 - $39.47 $2.71 Million - $3.58 Million	90,632 Added 433.56%	111,536 $3.46 Million
Q2 2021 Aug 12, 2021	BUY	$17.99 - $40.02 $376,062 - $836,578	20,904 New	20,904 $665,000

Others Institutions Holding RAPT

# of Institutions

104

Shares Held

27.1M

Call Options Held

26.7K

Put Options Held

2.4K

View Full List

About RAPT Therapeutics, Inc.

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $26.1M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

More about RAPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Rapt Therapeutics, Inc. Transaction History